These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
497 related articles for article (PubMed ID: 8389256)
1. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256 [TBL] [Abstract][Full Text] [Related]
2. Tumour suppressor p53 and Rb genes in human hepatocellular carcinoma. Lin Y; Shi CY; Li B; Soo BH; Mohammed-Ali S; Wee A; Oon CJ; Mack PO; Chan SH Ann Acad Med Singap; 1996 Jan; 25(1):22-30. PubMed ID: 8779541 [TBL] [Abstract][Full Text] [Related]
3. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India. Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214 [TBL] [Abstract][Full Text] [Related]
4. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma. Shieh YS; Nguyen C; Vocal MV; Chu HW Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes. Uchida T; Takahashi K; Tatsuno K; Dhingra U; Eliason JF Int J Cancer; 1996 Sep; 67(6):892-7. PubMed ID: 8824564 [TBL] [Abstract][Full Text] [Related]
6. Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1. Park US; Su JJ; Ban KC; Qin L; Lee EH; Lee YI Gene; 2000 Jun; 251(1):73-80. PubMed ID: 10863098 [TBL] [Abstract][Full Text] [Related]
7. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan. Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260 [TBL] [Abstract][Full Text] [Related]
8. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries. Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820 [TBL] [Abstract][Full Text] [Related]
9. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure. Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059 [TBL] [Abstract][Full Text] [Related]
10. Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China. Huang XH; Sun LH; Lu DD; Sun Y; Ma LJ; Zhang XR; Huang J; Yu L World J Gastroenterol; 2003 Apr; 9(4):692-5. PubMed ID: 12679912 [TBL] [Abstract][Full Text] [Related]
11. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015 [TBL] [Abstract][Full Text] [Related]
12. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet. Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184 [TBL] [Abstract][Full Text] [Related]
13. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico. Soini Y; Chia SC; Bennett WP; Groopman JD; Wang JS; DeBenedetti VM; Cawley H; Welsh JA; Hansen C; Bergasa NV; Jones EA; DiBisceglie AM; Trivers GE; Sandoval CA; Calderon IE; Munoz Espinosa LE; Harris CC Carcinogenesis; 1996 May; 17(5):1007-12. PubMed ID: 8640905 [TBL] [Abstract][Full Text] [Related]
15. Genetic heterogeneity of hepatocellular carcinoma. Unsal H; Yakicier C; Marçais C; Kew M; Volkmann M; Zentgraf H; Isselbacher KJ; Ozturk M Proc Natl Acad Sci U S A; 1994 Jan; 91(2):822-6. PubMed ID: 8290606 [TBL] [Abstract][Full Text] [Related]
16. High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal. Coursaget P; Depril N; Chabaud M; Nandi R; Mayelo V; LeCann P; Yvonnet B Br J Cancer; 1993 Jun; 67(6):1395-7. PubMed ID: 8390289 [TBL] [Abstract][Full Text] [Related]
17. [The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma]. Qin L; Tang Z; Liu K Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):405-8. PubMed ID: 8697987 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis B and alterations of the p53 tumor suppressor gene in hepatocellular carcinoma. Goldblum JR; Bartos RE; Carr KA; Frank TS Am J Surg Pathol; 1993 Dec; 17(12):1244-51. PubMed ID: 8238731 [TBL] [Abstract][Full Text] [Related]
19. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas. Hosono S; Chou MJ; Lee CS; Shih C Oncogene; 1993 Feb; 8(2):491-6. PubMed ID: 8093978 [TBL] [Abstract][Full Text] [Related]
20. Aberrations of p53 gene in human hepatocellular carcinoma from China. Li D; Cao Y; He L; Wang NJ; Gu JR Carcinogenesis; 1993 Feb; 14(2):169-73. PubMed ID: 8382111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]